A comparison of group sequential methods for binary longitudinal data

Statistics in Medicine

Volumn 22, Issue 4, 2003, Pages 501-515

  Spiessens, Bart ^a   Lessaffre, Emmanuel ^a   Verbeke, Geert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Generalized estimating equations; Generalized linear mixed models; Interim analyses; Logistic regression; Repeated measurements

Indexed keywords

ANTIFUNGAL AGENT;

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; COVARIANCE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MATHEMATICAL COMPUTING; ONYCHOMYCOSIS; PROBABILITY; RANDOMIZATION; STATISTICAL MODEL;

ANTIFUNGAL AGENTS; BELGIUM; CONTROLLED CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; FOOT DERMATOSES; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LONGITUDINAL STUDIES; ONYCHOMYCOSIS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0037470261     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1361     Document Type: Article

References (33)

1. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Springer Series in Statistics, Springer-Verlag: New York, 2000.
2. Lee JW, DeMets DL. Sequential comparison of changes with repeated measurements data. Journal of the American Statistical Association 1991; 86:757-762.
3. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-974.
4. Lee SJ, Kim K, Tsiatis AA. Repeated significance testing in longitudinal clinical trials. Biometrika 1996; 83: 779-789.
5. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
6. Spiessens B, Lesaffre E, Verbeke G, Kim K, DeMets DL. An overview of group sequential methods in longitudinal clinical trials. Statistical Methods in Medical Research 2000; 9:497-515.
7. Kim K, DeMets DL. Design and analysis of group sequential tests based on the type I error spending rate function. Biometrika 1987; 74:149-154.
8. Kim K, DeMets DL. Sample size determination for group sequential clinical trials with immediate response. Statistics in Medicine 1992; 11:1391-1399.
9. Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implication on the design and analysis of group sequential studies. Journal of the American Statistical Association 1997; 92:1342-1350.
10. Jennison CJ, Turnbull BW. Group sequential analysis incorporating covariate information. Journal of the American Statistical Association 1997; 92:1330-1341.
11. Stiratelli R, Laird N, Ware JH. Random-effects models for serial observations with binary responses. Biometrics 1984; 40:961-971.
12. Zeger SL, Liang K-Y, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44:1049-1060.
13. Neuhaus JM, Kalbfleisch JD, Hauck WW. A comparison of cluster-specific and population-averaged approaches for analyzing correlated binary data. International Statistical Review 1991; 59:25-30.
14. Little RJA, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 1987.
15. De Backer M, De Vroey C, Lesaffre E, Scheys I, De Keyser P. Twelve weeks of continuous oral therapy for toenail onychomychosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. Journal of the American Academy of Dermatology 1998; 38:S57-63.
16. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey. British Journal of Dermatology 1992; 126 Suppl. 39:23-27.
17. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
18. Kim K, Tsiatis AA, Mehta CR. Computational issues in information-based group sequential clinical trials, 2001 Journal of the Japanese Society of Computational Statistics 2002; 15 (in press).
19. Jennison CJ, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall/CRC: Boca Raton, Florida, 2000.
20. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
21. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-199.
22. Armitage P, McPherson, CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A 1969; 132:235-244.
23. Reboussin DM, DeMets DL, Kim K, Lan KKG. Computations for group sequential boundaries using the Lan-DeMets spending function method. Controlled Clinical Trials 2000; 21:190-207.
24. Kim K, Boucher H, Tsiatis AA. Design and analysis of group sequential logrank tests in maximum duration versus information trials. Biometrics 1995; 51:988-1000.
25. Lan KKG, DeMets DL. Group sequential procedures: calendar versus information time. Statistics in Medicine 1989; 8:1191-1198.
26. Lan KKG, Reboussin DM, DeMets DL. Information and information fractions for design and sequential monitoring of clinical trials. Communications in Statistics, Part A - Theory and Methods 1994; 23: 403-420.
27. SAS Institute Inc. SAS OnlineDoc, Version 8. SAS Institute Inc.: Cary NC, 1999.
28. Hedeker D, Gibbons RD. MIXOR: a computer program for mixed-effects ordinal regression analysis. Computer Methods and Programs in Biomedicine 1996; 49:157-176.
29. Lesaffre E, Spiessens B. On the effect of the number of quadrature points in a logistic random-effects model: an example. Applied Statistics 2001; 50:325-335.
30. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Clarendon Press: Oxford, 1994.
31. Wei LJ, Su JQ, Lachin JM. Interim analyses with repeated measurements in a sequential clinical trial. Biometrika 1990; 77:359-364.
32. Lee JW, DeMets DL. Group sequential comparison of changes: ad-hoc versus more exact method. Biometrics 1995; 51:21-30.
33. Aptech Systems Inc. GAUSS for Windows NT/95, Version 3.2.34. Aptech Systems Inc.: Maple Valley, WA, 1998.